AstraZeneca to manufacture cancer killer in Singapore

Mon, May 20, 2024
By editor
1 MIN READ

Health

ASTRAZeneca says it  will invest 1.5 billion U.S. dollars in building a manufacturing facility in Singapore for antibody drug conjugates (ADCs).

The biopharmaceutical giant announced on Monday.

AstraZeneca aimed to start designing and construction of the manufacturing facility by the end of this year, with targeted operational readiness from 2029.

According to the company ADCs are next-generation treatments that deliver highly potent cancer-killing agents directly to cancer cells through a targeted antibody. (Xinhua/NAN)

A.

-May 20, 2024 @ 11:56 GMT|

Tags:


Tension in Oyo as doctor, 3 nurses die in same hospital within 72 hrs

RESIDENTS of Saki, in Saki West Local Government Area of Oyo State, particularly those living around Almusharaf Hospital, Oke Sunah,...

Read More
FG to finalise guidelines on organ donation, transplantation

THE Federal Government is in the final stages of developing guidelines for organ donation and transplantation in Nigeria. Prof. Philip...

Read More
ANALYSIS: Rescuing 24.6m Nigerian children from harmful labour

By Ijeoma Popoola, CHILD labour has remained a challenge to Nigeria and many other countries. According to the International Labour...

Read More